References
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- JAPANESE GASTRIC CANCER A. Japanese Classification of Gastric Carcinoma – 2nd English Edition. Gastric Cancer. 1998;1(1):10–24.
- Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
- Shen L, Shan YS, Hu HM, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535–e547.
- Min YW, Min BH, Lee JH, et al. Endoscopic treatment for early gastric cancer. World J Gastroenterol. 2014;20(16):4566–4573.
- Ryu SJ, Kim BW, Kim BG, et al Endoscopic submucosal dissection versus surgical resection for early gastric cancer: a retrospective multicenter study on immediate and long-term outcome over 5 years. Surg Endosc. 2016;30(12):5283–5289.
- Jeon HK, Kim GH, Lee BE, et al. Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis. Gastric Cancer. 2018;21(1):133–143.
- Bollschweiler E, Berlth F, Baltin C, et al. Treatment of early gastric cancer in the Western World. World J Gastroenterol. 2014;20(19):5672–5678.
- Draganov PV, Coman RM, Gotoda T. Training for complex endoscopic procedures: how to incorporate endoscopic submucosal dissection skills in the West? J. Expert Rev Gastroenterol Hepatol. 2014;8(2):119–121.
- JAPANESE GASTRIC CANCER A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017; 20(1):1–19.
- Park CH, Shin S, Park JC, et al. Long-term outcome of early gastric cancer after endoscopic submucosal dissection: expanded indication is comparable to absolute indication. Dig Liver Dis. 2013;45(8):651–656.
- Kim DY, Joo JK, Ryu SY, et al. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma. WJG. 2004;10(5):737–740.
- Roviello F, Rossi S, Marrelli D, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94(4):275–280.
- Li X, Liu S, Yan J, et al. The characteristics, prognosis, and risk factors of lymph node metastasis in early gastric cancer. Gastroenterol Res Pract. 2018;2018:6945743.
- Chu YN, Yu YN, Jing X, et al. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer. WJG. 2019;25(35):5344–5355.
- Song SY, Park S, Kim S, et al. Characteristics of intramucosal gastric carcinoma with lymph node metastatic disease. Histopathology. 2004;44(5):437–444.
- Saragoni L, Morgagni P, Gardini A, et al. Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification. Gastric Cancer. 2013;16(4):549–554.
- Holscher AH, Drebber U, Monig SP, et al. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg. 2009;250(5):791–797.
- Ahmad R, Setia N, Schmidt BH, et al. Predictors of lymph node metastasis in western early gastric cancer. J Gastrointest Surg. 2016;20(3):531–538.
- Islami F, Desantis CE, Jemal A. Incidence trends of esophageal and gastric cancer subtypes by race, ethnicity, and age in the United States, 1997–2014. Clin Gastroenterol Hepatol. 2019;17(3):429–439.
- Noh SH, Hyung W J, Cheong JH. Minimally invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol. 2005;90(3):188–193. discussion 93–4.
- Draganov PV, Wang AY, Othman MO, et al. AGA Institute Clinical Practice Update: endoscopic submucosal dissection in the United States. Clin Gastroenterol Hepatol. 2019;17(1):16–25 e1.
- Pereira MA, Ramos M, Dias AR, et al. Risk factors for lymph node metastasis in western early gastric cancer after optimal surgical treatment. J Gastrointest Surg. 2018;22(1):23–31.
- Shin N, Jeon TY, Kim GH, et al. Unveiling lymph node metastasis in early gastric cancer. World J Gastroenterol. 2014;20(18):5389–5395.
- Hanada Y, Choi AY, Hwang JH, et al. Low frequency of lymph node metastases in patients in the United States with early-stage gastric cancers that fulfill Japanese endoscopic resection criteria. Clin Gastroenterol Hepatol. 2019;17(9):1763–1769.
- Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3(4):219–225.
- Fang WL, Huang KH, Lan YT, et al. The risk factors of lymph node metastasis in early gastric cancer. Pathol Oncol Res. 2015;21(4):941–946.
- Katai H, Ishikawa T, Akazawa K, Registration Committee of the Japanese Gastric Cancer Association, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer. 2018;21(1):144–154.
- Noguchi Y, Yoshikawa T, Tsuburaya A, et al. Is gastric carcinoma different between Japan and the United States?. Cancer. 2000;89(11):2237–2246.
- Ito Y, Miyashiro I, Ishikawa T, et al. Determinant factors on differences in survival for gastric cancer between the US and Japan using nationwide databases. J Epidemiol. 2020. DOI:10.2188/jea.JE20190351
- Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev. 2015;(2):CD009944.
- Yan C, Zhu ZG, Yan M, et al. Value of multidetector-row computed tomography in the preoperative T and N staging of gastric carcinoma: a large-scale Chinese study. J Surg Oncol. 2009;100(3):205–214.
- Kim SM, Lee H, Min BH, et al. A prediction model for lymph node metastasis in early-stage gastric cancer: toward tailored lymphadenectomy. J Surg Oncol. 2019;120(4):670–675.
- Mu J, Jia Z, Yao W, et al. Predicting lymph node metastasis in early gastric cancer patients: development and validation of a model. Future Oncol. 2019;15(31):3609–3617.